The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
IFN-γ to improve immunotherapy for melanoma.
Marco Donia
No relevant relationships to disclose
Morten Hansen
No relevant relationships to disclose
Sarah Louise Sendrup
No relevant relationships to disclose
Eva Ellebaek
No relevant relationships to disclose
Trine Zeeberg Iversen
No relevant relationships to disclose
Mads Hald Andersen
No relevant relationships to disclose
Per thor Straten
No relevant relationships to disclose
Inge Marie Svane
No relevant relationships to disclose